Panacea Biotec
Panacea Biotec GmbH is delivers and markets products in transplantation, immunsuppression and anti-infection.
Launch date
Employees
Market cap
-
Enterprise valuation
CAD785m—1.2b (Dealroom.co estimates Apr 2019.)
Lalru Punjab (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | $144m | Late VC | |
| N/A | $24.3m | Grant | |
$16.1m | Secondary | ||
* | $20.0m | Debt | |
| Total Funding | CAD230m | ||
Related Content
Recent News about Panacea Biotec
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.